Diversity and Inclusion Meets Quality and Safety: It's Not Quality Unless It's Quality for All - Insights

In this sketchnote, John Knudsen, M.D., discusses the impact of systemic discrimination, bias, and racism on the quality and safety of health care. He calls for data to drive action on inequities and measure the success of interventions.

Culturally Sensitive and Medically Appropriate Care for Transgender Patients Sketchnote - Insights

In this sketchnote, Caroline Davidge-Pitts, M.B., B.Ch., and Todd Nippoldt, M.D., share inclusive terminology and lessons learned from Mayo Clinic’s Transgender Intersex Specialty Care Clinic.

Tick Dragging with Bobbi Pritt, M.D. - Insights

On a recent tick drag with Minnesota Department of Health researchers, Bobbi Pritt, M.D., Director of the Clinical Parasitology Lab and Co-Director of Vector-Borne Diseases Lab Services in Mayo Clinic’s Department of Lab Medicine and...

Specialized BioPharma accessioning team collaborates for quality assurance - Insights

At Mayo Clinic, quality is not an act, it’s a habit. This commitment extends into BioPharma Diagnostics, where a team of four quality assurance assistants and three lab processing assistants has recently come together as the BioPharma...

Mayo Clinic Laboratory and Pathology Research Roundup: July 9 - Insights

This week’s Research Roundup highlights the association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer.

CPT codes and LOINC update: August 2024 - Insights

This page lists updates posted to Mayo Clinic Labs during the month of August.

CPT codes and LOINC update: May 2024 - Insights

This page includes updates posted to Mayo Clinic Labs during the month of May.

Mayo Clinic Laboratory and Pathology Research Roundup: May 14 - Insights

This week's research roundup feature: Despite advances in understanding the genetic abnormalities in myeloproliferative neoplasms (MPNs) and the development of JAK2 inhibitors, there is an urgent need to devise new treatment strategies,...

Mayo Clinic Laboratory and Pathology Research Roundup: March 5 - Insights

This week's research roundup feature: Variants of uncertain significance (VUSs) in BRCA2 are a common result of hereditary cancer genetic testing. While more than 4,000 unique VUSs, comprised of missense or intronic variants, have been...

Meet Mukesh Pandey, Ph.D. - Developing a New Drug to Detect Prostate Cancer in Its Earliest Stages - Insights

Dr. Pandey is a nuclear radiology researcher working with a team to develop a new radioactive tracer to detect prostate cancer.